-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Misses Q4 EPS by $1.41, Offers Guidance
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Tops Q3 EPS by $1.32
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Lowered to $76 at BofA Securities
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) reported revenue at $190 million, provides guidance
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results
-
1,231,056 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


